1
|
Barbiero A, Spinicci M, Aiello A, Maruotto M, Antonello RM, Formica G, Piccica M, Isola P, Parisio EM, Nardone M, Valentini S, Mangano V, Brunelli T, Bianchi L, Bartalesi F, Costa C, Sambo M, Tumbarello M, Sani S, Fabiani S, Rossetti B, Nencioni C, Lanari A, Aquilini D, Montorzi G, Venturini E, Galli L, Rinninella G, Falcone M, Ceriegi F, Amadori F, Vincenti A, Blanc P, Vellere I, Tacconi D, Luchi S, Moneta S, Massi D, Brogi M, Voller F, Gemmi F, Rossolini GM, Cusi MG, Bruschi F, Bartoloni A, Zammarchi L. The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study. Microorganisms 2024; 12:1963. [PMID: 39458272 PMCID: PMC11509187 DOI: 10.3390/microorganisms12101963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2024] [Revised: 09/14/2024] [Accepted: 09/16/2024] [Indexed: 10/28/2024] Open
Abstract
Human leishmaniasis is facing important epidemiological changes in Southern Europe, driven by increased urbanization, climate changes, emerging of new animal reservoirs, shifts in human behavior and a growing population of immunocompromised and elderly individuals. In this evolving epidemiological landscape, we analyzed the clinical and epidemiological characteristics of human leishmaniasis in the Tuscany region of Central Italy. Through a multicentric retrospective analysis, we collected clinical and demographic data about all cases of leishmaniasis recorded between 2018 and 2023. We observed 176 cases of human leishmaniasis, with 128 (72.7%) visceral leishmaniasis (VL) and 47 (26.7%) cutaneous leishmaniasis (CL). Among these, 92.2% of VL and 85.1% of CL cases were autochthonous. The cumulative incidence of autochthonous human leishmaniasis was 0.22 cases per 100,000 inhabitants in 2018, but reached 1.81/100,000 in 2023. We identified three main areas of transmission: around the city of Florence (North-East Tuscany), around Grosseto city (South-West Tuscany) and Elba Island. Our findings confirm that the epidemiology of leishmaniasis is undergoing significant changes in Central Italy. Awareness towards this emerging health threat and surveillance strategies need to be improved in order to reliably assess the disease's burden. Further research is needed in a "One-Health" perspective, to clarify the epidemiological dynamics at the environmental, reservoir, vector and human levels. The role of climate change and specific climatic factors affecting the epidemiological patterns of human leishmaniasis should be assessed. Further knowledge in these fields would promote targeted control and prevention strategies at regional and national levels.
Collapse
Affiliation(s)
- Anna Barbiero
- Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy; (A.B.)
| | - Michele Spinicci
- Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy; (A.B.)
- Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy
| | - Andrea Aiello
- Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy; (A.B.)
| | - Martina Maruotto
- School of Human Health Sciences, University of Florence, 50121 Florence, Italy
| | - Roberta Maria Antonello
- Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy; (A.B.)
| | - Giuseppe Formica
- Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy; (A.B.)
| | - Matteo Piccica
- Infectious Diseases Unit, Department of Multidimensional Medicine, Santa Maria Annunziata Hospital, Bagno a Ripoli, 50012 Florence, Italy
| | - Patrizia Isola
- Laboratory Medicine Unit, Azienda USL Toscana Nord Ovest, 56121 Livorno, Italy
| | - Eva Maria Parisio
- Clinical Pathology and Microbiology Unit, San Luca Hospital, 55100 Lucca, Italy
| | - Maria Nardone
- Laboratory of Chemical-Clinical Analysis, San Luca Hospital, 56121 Lucca, Italy
| | - Silvia Valentini
- Infectious Disease Department, Misericordia Hospital, 58100 Grosseto, Italy
| | - Valentina Mangano
- Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy
| | | | - Loria Bianchi
- Microbiology Unit, S. Jacopo Hospital, 51100 Pistoia, Italy
| | - Filippo Bartalesi
- Infectious Diseases Unit, Department of Multidimensional Medicine, Santa Maria Annunziata Hospital, Bagno a Ripoli, 50012 Florence, Italy
| | - Cecilia Costa
- Infectious Diseases Unit, Department of Multidimensional Medicine, Santa Maria Annunziata Hospital, Bagno a Ripoli, 50012 Florence, Italy
| | - Margherita Sambo
- Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy
- Infectious and Tropical Diseases Unit, Azienda Ospedaliero Universitaria Senese, 53100 Siena, Italy
| | - Mario Tumbarello
- Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy
- Infectious and Tropical Diseases Unit, Azienda Ospedaliero Universitaria Senese, 53100 Siena, Italy
| | - Spartaco Sani
- Infectious Diseases Unit, Ospedali Riuniti di Livorno, 57124 Livorno, Italy
| | - Silvia Fabiani
- Infectious Diseases Unit, Ospedali Riuniti di Livorno, 57124 Livorno, Italy
| | - Barbara Rossetti
- Infectious Diseases Unit, Ospedale Misericordia, 5810 Grosseto, Italy
| | - Cesira Nencioni
- Infectious Diseases Unit, Ospedale Misericordia, 5810 Grosseto, Italy
| | - Alessandro Lanari
- Infectious Diseases Unit, Ospedale Misericordia, 5810 Grosseto, Italy
| | | | - Giulia Montorzi
- Infectious Diseases Unit, S. Stefano Hospital, 59100 Prato, Italy
| | - Elisabetta Venturini
- Infectious Diseases Unit, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
| | - Luisa Galli
- Infectious Diseases Unit, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
- Section of Pediatrics, Department of Health Science, University of Florence, 50121 Florence, Italy
| | - Giada Rinninella
- Infectious Diseases Unit, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
| | - Marco Falcone
- Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Pisa University Hospital, University of Pisa, 56126 Pisa, Italy
| | - Federica Ceriegi
- Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Pisa University Hospital, University of Pisa, 56126 Pisa, Italy
| | | | | | - Pierluigi Blanc
- Infectious Diseases Unit, S. Jacopo Hospital, 51100 Pistoia, Italy
| | - Iacopo Vellere
- Infectious Diseases Unit, S. Jacopo Hospital, 51100 Pistoia, Italy
| | - Danilo Tacconi
- Infectious Diseases Unit, Ospedale San Donato, 52100 Arezzo, Italy
| | - Sauro Luchi
- Infectious Diseases and Epatology Unit, San Luca Hospital, 55100 Lucca, Italy
| | - Sara Moneta
- Infectious Diseases and Epatology Unit, San Luca Hospital, 55100 Lucca, Italy
| | - Daniela Massi
- Section of Pathology, Department of Health Sciences, University of Florence, 50121 Florence, Italy
| | - Michela Brogi
- Unit of Infectious Diseases, Department of Medical Specialties, Empoli, 50129 Florence, Italy
| | - Fabio Voller
- Unit of Epidemiology, Regional Health Agency of Tuscany, 50141 Florence, Italy
| | - Fabrizio Gemmi
- Quality and Equity Unit, Regional Health Agency of Tuscany, 50141 Florence, Italy
| | - Gian Maria Rossolini
- Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy; (A.B.)
- Microbiology and Virology Unit, Careggi University Hospital, 50134 Florence, Italy
| | - Maria Grazia Cusi
- Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy
| | - Fabrizio Bruschi
- Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy
- Programma di Monitoraggio delle Parassitosi e Formulazione di Nuovi Algoritmi Diagnostici, AOU Pisana, 56126 Pisa, Italy
| | - Alessandro Bartoloni
- Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy; (A.B.)
- Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy
| | - Lorenzo Zammarchi
- Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy; (A.B.)
- Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy
| |
Collapse
|
2
|
Gashaw B, Yizengaw E, Nibret E, Workineh A, Tilahun F. Case Notification of Cutaneous Leishmaniasis at Different Elevations in the North-Central Ethiopia from 2018 To 2022. IRANIAN JOURNAL OF PARASITOLOGY 2024; 19:349-357. [PMID: 39318813 PMCID: PMC11417984 DOI: 10.18502/ijpa.v19i3.16395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 05/08/2024] [Accepted: 07/10/2024] [Indexed: 09/26/2024]
Abstract
Background We aimed to analyze a four-year trend of Cutaneous leishmaniasis (CL) to determine risk levels and hotspots in North-central Ethiopia. Methods This retrospective study was conducted at Boru Meda Hospital (BMH) from March to April 2023, focusing on CL patients treated at the leishmaniasis treatment center (LTC). Data collected included age, gender, CL type, and other clinical factors. Each patient's origin was traced and geographically mapped by elevation to assess CL risk levels. Results There were a total of 573 CL patients reported from 46 districts, with a higher number of male patients (n=356) compared to female patients (n=217) (P <0.001). The median age of the patients was 21 years [15-30], with the highest number of CL cases observed among individuals aged 16 to 30 years. The majority of cases (69%) presented with localized CL (LCL). About 39% of patients had a previous treatment history for CL. A significant clustering of CL cases was observed at elevation of 2301-3300 meters above sea level (χ2:17.5; P <0.001), with the highest incidence (case notification) of 14.2/100,000 population. Conclusion Foci of CL, were burdened at higher elevations and no clinical variation were observed between elevation differences. The majority of cases were concentrated in an area covering approximately 21.4% of the total land mass. CL continues to be a significant issue in North-central Ethiopia and has the potential to spread to new areas.
Collapse
Affiliation(s)
- Bizuayehu Gashaw
- Amhara National Regional State Health Bureau, Bahir Dar, Ethiopia
- Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia
| | - Endalew Yizengaw
- Department of Medical Laboratory Science, College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia
- Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia
| | - Endalkachew Nibret
- Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia
- Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia
| | - Addisu Workineh
- Amhara National Regional State Health Bureau, Bahir Dar, Ethiopia
| | | |
Collapse
|
3
|
Amane M, El Mazini S, Echchakery M, Hafidi M, Lemrani M, Boussaa S. Entomological, parasitological and molecular investigations in a new focus of cutaneous leishmaniasis in Youssoufia region, Morocco. Zoonoses Public Health 2024; 71:248-257. [PMID: 38105536 DOI: 10.1111/zph.13105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2023] [Revised: 12/05/2023] [Accepted: 12/09/2023] [Indexed: 12/19/2023]
Abstract
BACKGROUND AND AIMS Leishmaniasis is a neglected tropical infection caused by Leishmania parasite that affect human and animal. In Morocco, the cutaneous leishmaniasis has spread substantially to the new areas. The surveillance limited to active foci may underestimate the occurrence of cutaneous leishmaniasis (CL). This study aims to investigate the local transmission of CL in rural districts of Youssoufia province, central Morocco, as a potential focus of CL. METHODS For this purpose, parasitological, molecular and entomological investigations were carried out in this area. Data collection concerns potential vectors and human cases. Thus, 402 patients were examined for suspected leishmaniasis lesions in three localities of the province of Youssoufia. In these same localities, 983 sand flies were collected by CDC light traps and sticky paper during one-night per month during 6 months. These sand flies were all identified morphologically using the Moroccan identification key. RESULTS The results showed that among the 25 skin lesions detected in a population of 402 individuals, 18 were confirmed by kDNA nested PCR as CL positive patients, of which only 25% were positive by direct examination. Leishmania tropica and Leishmania major were identified as causative agents of CL in the study area. Direct parasitological examination showed a low sensitivity (27.78%), especially for L. major, although its specificity was evaluated at 100%. Regarding entomological results, both genera of the Moroccan sand fly were collected in the study area: Genus/Phlebotomus (75.28%) and Sergentomyia (24.72%). Phlebotomus (P) papatasi, the proven vector of L. major, was the most abundant species (33.98%), followed by Paralongicollum sergenti (22.58%), the confirmed vector of L. tropica; while Sergentomyia (S) minuta, P. longicuspis, S. fallax and P. kazeruni were collected with, respectively, 17.60%, 16.99%, 7.12% and 1.73%. CONCLUSION This study constitutes the first report of CL in the study areas, as well as the coexistence of L. tropica and L. major in these rural localities. Local transmission of CL is highly probable, as indicated by the prevalence of the two proven vectors of L. major and L. tropica. To control the spread of this disease, our results suggest the use of highly sensitive molecular methods to detect CL cases in potential leishmaniasis foci, which will improve surveillance.
Collapse
Affiliation(s)
- Mounia Amane
- Microbial Biotechnologies, Agrosciences and Environment Laboratory (BioMAgE), Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakesh, Morocco
| | - Sara El Mazini
- Laboratory of Parasitology and Vector-Borne-Diseases, Institut Pasteur du Maroc, Casablanca, Morocco
- Laboratory of Microbial Biotechnology and Bioactive Molecules, Faculty of Sciences and Technologies, Sidi Mohammed Ben Abdellah University, Fes, Morocco
| | - Mohamed Echchakery
- Microbial Biotechnologies, Agrosciences and Environment Laboratory (BioMAgE), Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakesh, Morocco
- Epidemiology and Biomedical Unit, Laboratory of Sciences and Health Technologies, Higher Institute of Health Sciences, Hassan First University, Settat, Morocco
| | - Mohamed Hafidi
- Microbial Biotechnologies, Agrosciences and Environment Laboratory (BioMAgE), Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakesh, Morocco
| | - Meryem Lemrani
- Laboratory of Parasitology and Vector-Borne-Diseases, Institut Pasteur du Maroc, Casablanca, Morocco
| | - Samia Boussaa
- Microbial Biotechnologies, Agrosciences and Environment Laboratory (BioMAgE), Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakesh, Morocco
- ISPITS-Higher Institute of Nursing and Technical Health Occupations, Ministry of Health and Social Protection, Rabat, Morocco
| |
Collapse
|
4
|
Layug PJ, Vats H, Kannan K, Arsenio J. Sex differences in CD8 + T cell responses during adaptive immunity. WIREs Mech Dis 2024:e1645. [PMID: 38581141 DOI: 10.1002/wsbm.1645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 02/08/2024] [Accepted: 03/14/2024] [Indexed: 04/08/2024]
Abstract
Biological sex is an important variable that influences the immune system's susceptibility to infectious and non-infectious diseases and their outcomes. Sex dimorphic features in innate and adaptive immune cells and their activities may help to explain sex differences in immune responses. T lymphocytes in the adaptive immune system are essential to providing protection against infectious and chronic inflammatory diseases. In this review, T cell responses are discussed with focus on the current knowledge of biological sex differences in CD8+ T cell mediated adaptive immune responses in infectious and chronic inflammatory diseases. Future directions aimed at investigating the molecular and cellular mechanisms underlying sex differences in diverse T cell responses will continue to underscore the significance of understanding sex differences in protective immunity at the cellular level, to induce appropriate T cell-based immune responses in infection, autoimmunity, and cancer. This article is categorized under: Immune System Diseases > Molecular and Cellular Physiology Infectious Diseases > Molecular and Cellular Physiology.
Collapse
Affiliation(s)
- Paul Jerard Layug
- Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
- Manitoba Centre for Proteomics and Systems Biology, Winnipeg, Manitoba, Canada
| | - Harman Vats
- Manitoba Centre for Proteomics and Systems Biology, Winnipeg, Manitoba, Canada
- Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Kamali Kannan
- Manitoba Centre for Proteomics and Systems Biology, Winnipeg, Manitoba, Canada
- Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Janilyn Arsenio
- Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
- Manitoba Centre for Proteomics and Systems Biology, Winnipeg, Manitoba, Canada
- Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
- Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
| |
Collapse
|